tadalafil
Generic: tadalafil
Labeler: direct rxDrug Facts
Product Profile
Brand Name
tadalafil
Generic Name
tadalafil
Labeler
direct rx
Dosage Form
TABLET
Routes
Active Ingredients
tadalafil 5 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
72189-145
Product ID
72189-145_397f5fde-810b-642f-e063-6294a90ae47b
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA209654
Listing Expiration
2026-12-31
Marketing Start
2020-11-12
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
72189145
Hyphenated Format
72189-145
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
tadalafil (source: ndc)
Generic Name
tadalafil (source: ndc)
Application Number
ANDA209654 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 5 mg/1
Packaging
- 30 TABLET in 1 BOTTLE (72189-145-30)
- 90 TABLET in 1 BOTTLE (72189-145-90)
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "397f5fde-810b-642f-e063-6294a90ae47b", "openfda": {"nui": ["N0000175599", "N0000020026"], "unii": ["742SXX0ICT"], "rxcui": ["403957"], "spl_set_id": ["b3ee8325-bcb2-43fd-e053-2a95a90a08c8"], "pharm_class_epc": ["Phosphodiesterase 5 Inhibitor [EPC]"], "pharm_class_moa": ["Phosphodiesterase 5 Inhibitors [MoA]"], "manufacturer_name": ["direct rx"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (72189-145-30)", "package_ndc": "72189-145-30", "marketing_start_date": "20201112"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (72189-145-90)", "package_ndc": "72189-145-90", "marketing_start_date": "20201112"}], "brand_name": "TADALAFIL", "product_id": "72189-145_397f5fde-810b-642f-e063-6294a90ae47b", "dosage_form": "TABLET", "pharm_class": ["Phosphodiesterase 5 Inhibitor [EPC]", "Phosphodiesterase 5 Inhibitors [MoA]"], "product_ndc": "72189-145", "generic_name": "TADALAFIL", "labeler_name": "direct rx", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TADALAFIL", "active_ingredients": [{"name": "TADALAFIL", "strength": "5 mg/1"}], "application_number": "ANDA209654", "marketing_category": "ANDA", "marketing_start_date": "20201112", "listing_expiration_date": "20261231"}